A friend recently tested positive for Covid-19. I started researching if there was anything that might help him. I came across Fluvoxamine. I'm blown away that that the people in charge aren't making this available without a prescription at every pharmacy in America.
Allysia Finley J in the WSJ wrote:
Researchers at McMaster University in Hamilton, Ontario, last winter launched a large clinical trial in Brazil. The results from their trial, published in the Lancet in October, were stunning: Fluvoxamine reduced the odds of hospitalization or emergency care by 66% and death by 90% among unvaccinated high-risk patients who mostly followed the treatment regimen—comparable to monoclonal antibodies. There was no difference in adverse effects between the fluvoxamine and placebo groups.
The three fluvoxamine trials were conducted while different variants were circulating, so there’s no reason to think the drug wouldn’t work as well against Omicron. A 10-day course of fluvoxamine costs $4, compared with the $2,100 the U.S. government has been paying for monoclonal antibodies, and $530 to $700 for a course of the Pfizer (Paxlovid) and Merck treatments. Multiple drugmakers manufacture fluvoxamine and could ramp up supply without much difficulty were demand to increase.
I can't believe I had never heard of it .Am I missing something? This seems like a legit study.
Instead, I've heard repeatedly of Paxlovid from Pfizer which also " reduced the risk of hospitalisation or death by almost 90%." Guess what? An article in the Wash Post says "there are less than 180,000 doses of the Pfizer drug, and it takes months to manufacture."
Sources below.
Doc/Scientists, can you tell me why everyone who tests positive for Covid-19 isn't being told about this drug which is readily available? I'm all for testing people. I've taken 2 at home Covid-19 tests during the holidays. If you test positive, stay away from Grandma and Grandpa and other vulnerable people. But shouldn't we also help the people who test positive?
https://www.wsj.com/articles/is-fluvoxamine-the-covid-miracle-drug-we-have-been-waiting-for-oral-pill-cheap-hospitalization-11640726605#comments_sectorhttps://www.washingtonpost.com/opinions/2021/12/30/omicron-variant-challenges-covid/